FDA Inspection 1158618 — Paul E. Ziajka, M.D., Ph.D.
The FDA completed an inspection of Paul E. Ziajka, M.D., Ph.D. on Dec 6, 2021 in Winter Park, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 6, 2021
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Winter Park, FL (United States)
Additional Details
Clinical Investigator (CI)